Welcome to the Porton Newsroom
Porton Gets Above-Average S&P Global Environmental, Social, and Governance (ESG) Score
Porton Released 2022 CSR Report
Porton Pharma Solutions Recognized by Roche Group as a Leading CDMO Service Provider
Porton Reports Strong Interim Results 2022
Porton Pharma Solutions Ltd. to Expand Operations in Europe
Porton Announced to Acquire China Gateway Pharmaceutical Development Co., Ltd.
Porton Plans to Invest 420 million to Expand CDMO Production Capacity of Small Molecule API
Porton Invests to Expand API CDMO Capacity
Porton expects strongly growth in revenue and net profit in 2021